C2N Diagnostics, a leader in advanced brain health diagnostics, is closely tracking decision by the U.S. Food and Drug Administration to approve donanemab for...
EmeritusDX, a rapidly growing cancer diagnostics and information company, announced a definitive agreement to acquire Sprint Diagnostics (SprintDX), with the goal to expand its...
INOVIO, a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases,...
CareCentrix, a leading home-centered care company, announced the launch of DME Navigator. This next-generation DME benefits management solution brings together best-in-class industry capabilities. Through...
